156 related articles for article (PubMed ID: 6245425)
41. Time dependence of interaction of misonidazole and WR-2721.
Rojas A; Denekamp J
Br J Radiol; 1983 Aug; 56(668):592-5. PubMed ID: 6307457
[No Abstract] [Full Text] [Related]
42. Selective inhibition of the nephrotoxicity of cis-dichlorodiammineplatinum(II) by WR-2721 without altering its antitumor properties.
Yuhas JM; Culo F
Cancer Treat Rep; 1980 Jan; 64(1):57-64. PubMed ID: 6247064
[TBL] [Abstract][Full Text] [Related]
43. Phosphatidylserine externalization during bone marrow cell death after treatment of mice with WR-2721 and gamma-rays.
Mazur L; Bochenek M; Augustynek A
Folia Biol (Krakow); 2002; 50(1-2):95-100. PubMed ID: 12597541
[TBL] [Abstract][Full Text] [Related]
44. [Radioprotective effects of YM-08310 on normal and malignant tissues (author's transl)].
Tsukiyama I
Nihon Igaku Hoshasen Gakkai Zasshi; 1978 Sep; 38(9):888-902. PubMed ID: 213767
[No Abstract] [Full Text] [Related]
45. [Autotransplantation of bone marrow to dogs irradiated at doses 2 to 5 times exceeding the absolutely fatal one].
Novikova MN; Kotliarov AM; Malanina VN; Nemenova NM; Chertkov IL
Probl Gematol Pereliv Krovi; 1972 Jun; 17(6):21-6. PubMed ID: 4618610
[No Abstract] [Full Text] [Related]
46. Determination of the radioprotective effects of topical applications of MEA, WR-2721, and N-acetylcysteine on murine skin.
Verhey LJ; Sedlacek R
Radiat Res; 1983 Jan; 93(1):175-83. PubMed ID: 6296910
[TBL] [Abstract][Full Text] [Related]
47. Effect of tumor size on S-2-(3-aminopropylamino)ethylphosphorothioic acid and misonidazole alteration of tumor response to cyclophosphamide.
Milas L; Ito H; Hunter N
Cancer Res; 1983 Jul; 43(7):3050-6. PubMed ID: 6303574
[TBL] [Abstract][Full Text] [Related]
48. Radioprotective activity of ethylcellulose microspheres containing WR 2721, after oral administration.
Fatome M; Courteille F; Laval JD; Roman V
Int J Radiat Biol Relat Stud Phys Chem Med; 1987 Jul; 52(1):21-9. PubMed ID: 3036725
[TBL] [Abstract][Full Text] [Related]
49. Radioprotective effects of kojic acid against mortality induced by gamma irradiation in mice.
Hosseinimehr SJ; Emami S; Zakaryaee V; Ahmadi A; Moslemi D
Saudi Med J; 2009 Apr; 30(4):490-3. PubMed ID: 19370273
[TBL] [Abstract][Full Text] [Related]
50. WR-2721 protection of pneumonitis and fibrosis in mouse lung after single doses of x rays.
Travis EL; Parkins CS; Holmes SJ; Down JD; Fowler JF
Int J Radiat Oncol Biol Phys; 1984 Feb; 10(2):243-51. PubMed ID: 6323362
[TBL] [Abstract][Full Text] [Related]
51. Suppression of delayed-type hypersensitivity to oxazolone in whole-body-irradiated mice and protection by WR-2721.
Srinivasan V; Weiss JF
Radiat Res; 1984 Jun; 98(3):438-44. PubMed ID: 6328568
[TBL] [Abstract][Full Text] [Related]
52. Influence of chlorpromazine, bleomycin and WR-2721 singly or in combination on the formation of radiation-induced micronuclei in mice bone marrow.
Jagetia GC
Strahlenther Onkol; 1994 Nov; 170(11):648-53. PubMed ID: 7526477
[TBL] [Abstract][Full Text] [Related]
53. Radioprotection of mouse testis by S-2-(3-aminopropylamino)ethylphosphorothioic acid.
Bhartiya J; Bhartiya HC
Radiobiol Radiother (Berl); 1985; 26(3):389-93. PubMed ID: 2997832
[No Abstract] [Full Text] [Related]
54. Protection by S-2-(3-aminopropylamino)ethylphosphorothioic acid against radiation- and cyclophosphamide-induced attenuation in antitumor resistance.
Milas L; McBride WH; Hunter N; Ito H
Cancer Res; 1984 Jun; 44(6):2382-6. PubMed ID: 6327014
[TBL] [Abstract][Full Text] [Related]
55. [Prevention of irradiation effects by means of transplantation of syngenic bone marrow stored at a temperature of -196 degrees C].
Daszyński J; Kotelba-Witkowska B; Klenowska M; Mościcka M
Acta Haematol Pol; 1974; 5(1):35-42. PubMed ID: 4595059
[No Abstract] [Full Text] [Related]
56. Studies on sulphydryl radioprotectors in mouse spleen and peripheral blood cells against gamma rays.
Kumar S; Popli MK; Kumar M; Uma Devi P
Radiobiol Radiother (Berl); 1985; 26(3):373-7. PubMed ID: 2997831
[No Abstract] [Full Text] [Related]
57. Activation of mouse spleen adenylate cyclase by WR-2721 and the GTP synthetic analogue.
Sołtysiak-Pawluczuk D; Bitny-Szlachto S
Acta Pol Pharm; 1982; 39(4):267-9. PubMed ID: 6299063
[No Abstract] [Full Text] [Related]
58. Radioprotection of mouse skin by WR-2721 in single and fractionated treatments.
Stewart FA; Rojas A
Br J Radiol; 1982 Jan; 55(649):42-7. PubMed ID: 6274467
[TBL] [Abstract][Full Text] [Related]
59. Rationale for initial clinical trials and future development of radioprotectors.
Phillips TL
Cancer Clin Trials; 1980; 3(2):165-73. PubMed ID: 6253097
[TBL] [Abstract][Full Text] [Related]
60. Protection of mouse jejunal crypt cells by WR-2721 after small doses of radiation.
Travis EL; Thames HD; Tucker SL; Watkins TL; Kiss I
Int J Radiat Oncol Biol Phys; 1986 May; 12(5):807-14. PubMed ID: 3011713
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
